Abstract

FDG-PET-derived textural features describing intra-tumor heterogeneity are increasingly investigated as imaging biomarkers. As part of the process of quantifying heterogeneity, image intensities (SUVs) are typically resampled into a reduced number of discrete bins. We focused on the implications of the manner in which this discretization is implemented. Two methods were evaluated: (1) RD, dividing the SUV range into D equally spaced bins, where the intensity resolution (i.e. bin size) varies per image; and (2) RB, maintaining a constant intensity resolution B. Clinical feasibility was assessed on 35 lung cancer patients, imaged before and in the second week of radiotherapy. Forty-four textural features were determined for different D and B for both imaging time points. Feature values depended on the intensity resolution and out of both assessed methods, RB was shown to allow for a meaningful inter- and intra-patient comparison of feature values. Overall, patients ranked differently according to feature values–which was used as a surrogate for textural feature interpretation–between both discretization methods. Our study shows that the manner of SUV discretization has a crucial effect on the resulting textural features and the interpretation thereof, emphasizing the importance of standardized methodology in tumor texture analysis.

Highlights

  • In recent years, oncological research has increasingly focused on the prediction of treatment outcome based on individual patient and tumor characteristics[1], aiming to avoid the one-size-fits-all treatment approach that under- and over-treats a large number of patients

  • None of the observed pairwise intra-class correlation coefficient (ICC) was higher than 0.85, meaning that textural features and their ascribed value depend on the intensity resolution used for standardized uptake values (SUVs) discretization

  • When aiming to identify and validate imaging biomarkers with tumor texture analysis of FDG-Positron emission tomography (PET), it is important that the textural feature values be directly comparable, both inter- and intra-patient, in order to derive meaningful conclusions

Read more

Summary

Introduction

Oncological research has increasingly focused on the prediction of treatment outcome based on individual patient and tumor characteristics[1], aiming to avoid the one-size-fits-all treatment approach that under- and over-treats a large number of patients. Imaging can play a crucial role here, as it allows for a non-invasive identification and characterization of the tumor[2,3]. PET imaging has been increasingly used for decision support[5], treatment planning[6,7] and response monitoring during radiotherapy[8]. The most widely used PET tracer is [18F] fluoro-2-deoxy-D-glucose (FDG), commonly quantified by standardized uptake values (SUVs)[9]. Derived SUV measurements, such as the maximum www.nature.com/scientificreports/

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call